Crescom (CEO, Jae Joon Lee), a company specializing in
artificial intelligence for automatic analysis of medical images, announced on
the 28th of November that its artificial intelligence solution for bone age
analysis, 'MediAI-BA', has been approved as a venture innovation procurement
product by the Public Procurement Service(PPS).
Venture startup innovation procurement products are
products or services designated for registration with Venture Nara. This is a
project by the Public Procurement Service(PPS) that aims to support the entry
and promotion of products from venture start-ups into the procurement market
and public purchasing channels. Among the products produced by venture, goods
or services with excellent technology and quality are approved through reviews
and recommendations from government agencies or through reviews by the Public
"MediAI-BA" is an artificial
intelligence-based solution for analyzing bone age. It utilizes a hybrid method
that incorporates patented technology to address the limitations of existing
bone age reading techniques, such as GP and TW3 while leveraging their
strengths. By improving the efficiency and accuracy of bone age analysis in
children and adolescents, this technology aids medical professionals in making
accurate and prompt diagnosis. Currently, MediAI-BA is being widely used by
around 300 medical hospitals and clinics, with a high level of satisfaction.
Jae Joon Lee, CEO of Crescom, said, "MediAI-BA
has been acknowledged for its exceptional quality and functionality, and has
been designated as a venture innovation procurement product." He further
added, "It will continue to serve as a solution that can contribute to the
overall well-being and development of children and adolescents."
Meanwhile, in addition to MediAI-BA, Crescom also has
MediAI-OA, an arthritis severity quantification analysis solution, MediAI-FX, a
wrist fracture detection solution capable of accurately interpreting
challenging scaphoid fractures, and MediAI-AS,
an automatic evaluation solution for ankylosing spondylitis.
(Photo provided by Crescom Co., Ltd.)